Need for a sustainable use of medicinal products: the impacts on the environment of ivermectin



It is worldwide recognized that the use of pharmaceuticals for human and veterinary
purposes could lead to unsustainable effects on the environment. A strategy to reduce
the impact of pharmaceuticals on the environment has been recently established at European level, where guidelines to evaluate the impacts of veterinary drugs used to treat
animal diseases are in place. The aim of this article is to focus on the worldwide used antiparasitic drug ivermectin (IVM) and its potential impact on the environment. A specific
section is related to the IVM resistance that the massive use of this drug could generate
enhancing the risk scenarios also for human health. The application of stringent measures
for the veterinary use of this substance, in line with the recommendations provided
by International frameworks such as One Health and EcoHealth, is recommended.

Share on



Laura Mancini - Istituto Superiore di Sanità

Ines Lacchetti - Istituto Superiore di Sanità

Filippo Chiudioni - Istituto Superiore di Sanità

Walter Cristiano - Istituto Superiore di Sanità

Kevin Di Domenico - Istituto Superiore di Sanità

Stefania Marcheggiani - Istituto Superiore di Sanità

Mario Carere - Istituto Superiore di Sanità

Luciana Bindi - Ministero della Salute

Silvio Borrello - Ministero della Salute

How to Cite
Mancini, L., Lacchetti, I., Chiudioni, F., Cristiano, W., Di Domenico, K., Marcheggiani, S., … Borrello, S. (2020). Need for a sustainable use of medicinal products: the impacts on the environment of ivermectin. Annali dell’Istituto Superiore Di Sanità, 56(4), 492–496. Retrieved from
  • Abstract viewed - 294 times